ProterixBio Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:ProterixBio Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12169
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ProterixBio Inc (ProterixBio), formerly BioScale Inc, is a medical device company that manufactures and markets ViBE platform products. The company offers ViBE platform, acoustic assays, ViBE software and custom assays, among others. Its ViBE platform enables non-optical detection and sensitive quantisation down to complex matrices. ProterixBio develops acoustic membrane microparticle technology, a homogeneous assay platform that improves the sensitivity and specificity of traditional reagents. The company’s research areas include pharmaceutical drug discovery and development, protein research, preclinical and clinical assays, translational biology and medicine, biochemical pharmacology, pharmaco-kinetics and pharmaco-dynamics. It serves biopharmaceutical companies, academic institutions and government laboratories, among others. BioScale is headquartered in Billerica, Massachusetts, the US.

ProterixBio Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ProterixBio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ProterixBio Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ProterixBio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ProterixBio Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
ProterixBio Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ProterixBio Inc, Medical Equipment, Deal Details 10
Venture Financing 10
BioScale Raises US$19 Million In Venture Financing 10
Bioscale Raises US$1 Million In Venture Financing 11
BioScale Raises US$3.8 Million Venture Financing Round 12
Bioscale Raises US$5.3 Million In Venture Financing 13
ProterixBio Inc – Key Competitors 14
ProterixBio Inc – Key Employees 15
ProterixBio Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Product News 17
May 22, 2018: ProterixBio Presents Results from Multiple COPD Clinical Studies at the American Thoracic Society International Conference 17
Sep 12, 2017: ProterixBio presents COPD clinical study results at the European Respiratory Society International Congress 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
ProterixBio Inc, Medical Equipment, Key Facts 2
ProterixBio Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ProterixBio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ProterixBio Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ProterixBio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ProterixBio Inc, Deals By Market, 2012 to YTD 2018 8
ProterixBio Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioScale Raises US$19 Million In Venture Financing 10
Bioscale Raises US$1 Million In Venture Financing 11
BioScale Raises US$3.8 Million Venture Financing Round 12
Bioscale Raises US$5.3 Million In Venture Financing 13
ProterixBio Inc, Key Competitors 14
ProterixBio Inc, Key Employees 15

List of Figures
ProterixBio Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ProterixBio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ProterixBio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ProterixBio Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ProterixBio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ProterixBio Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
ProterixBio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ProterixBio Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[ProterixBio Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Therapeutic Solutions International Inc (TSOI):医療機器:M&Aディール及び事業提携情報
    Summary Therapeutic Solutions International Inc (Therapeutic Solutions) is a pharmaceutical company that offers supplements. The company offers products such as DermalStilbene, NanoStilbene and ProJuvenol. Its ProJuvenol consists of anti-aging ingredients which helps for a healthy functionality for …
  • Zeltiq Aesthetics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Zeltiq Aesthetics Inc (Zeltiq), formerly Juniper Medical Inc, a subsidiary of Allergan Plc, is a medical technology company that develops and commercializes non-invasive products for the reduction of fat, selectively. The company offers CoolSculpting system, which uses proprietary controlled …
  • ImCheck Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary ImCheck Therapeutics SAS (ImCheck Therapeutics) is an independent biotechnology company that develops drugs for cancer and auto-immune disorders. The company is developing two first-in-class immunomodulator antibodies that are effective against adaptive and innate immunity to treat cancer an …
  • Shell Oman Marketing Co (SOMS):企業の財務・戦略的SWOT分析
    Summary Shell Oman Marketing Co (Shell Oman), formerly Shell Marketing (Oman) Ltd, is an oil and gas company that markets fuel and lubricants. The company provides engine oils and grease for cars, motorcycles and trucks. It also markets Shell automotive, aviation and marine products. Shell Oman owns …
  • ASV Holdings, Inc. (ASV):企業の財務・戦略的SWOT分析
    ASV Holdings, Inc. (ASV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Abide Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Abide Therapeutics Inc (Abide) is a clinical development stage company that discovers and develops therapeutic potential of serine hydrolases to transform the lives of patients with serious unmet medical needs. The company’s pipeline include ABX-1431, a first-in-class inhibitor of the serine …
  • Australia and New Zealand Banking Group Ltd:企業の戦略・SWOT・財務分析
    Australia and New Zealand Banking Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Australia and New Zealand Banking Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Avacta Group Plc (AVCT):医療機器:M&Aディール及び事業提携情報
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products that include optim and sensipod. It also develops UCB celltech that is an analytical instrument. Avacta’s sensipod is an …
  • VEON Ltd:企業の戦略・SWOT・財務情報
    VEON Ltd - Strategy, SWOT and Corporate Finance Report Summary VEON Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Smith & Nephew Plc (SN.):企業の財務・戦略的SWOT分析
    Smith & Nephew Plc (SN.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Helix BioMedix Inc:企業の戦略的SWOT分析
    Helix BioMedix Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Crew Energy Inc (CR):石油・ガス:M&Aディール及び事業提携情報
    Summary Crew Energy Inc (Crew Energy) is an exploration and production company that offers our long-term production and development of crude oil and natural gas resources. The company offers exploration, development, strategic acquisitions, operations, management, and production programs. It operate …
  • Alfa Laval AB (ALFA)-石油・ガス分野:企業M&A・提携分析
    Summary Alfa Laval AB (Alfa Laval) is a provider of specialized products and solutions for heat transfer, separation and fluid handling. Its product portfolio includes centrifuges, pumps and valves, heat exchangers, thermal fluid systems, boilers, decanters, burners, evaporation systems, high speed …
  • Pacific Ethanol Inc (PEIX):企業の財務・戦略的SWOT分析
    Pacific Ethanol Inc (PEIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Antero Resources Corp (AR):石油・ガス:M&Aディール及び事業提携情報
    Summary Antero Resources Corp (Antero) is an independent oil and natural gas company that explores, develops, produces and sells natural gas and oil from the Appalachia Basin. It gather and process wellhead natural gas and produce natural gas liquids (NGLs). The company also purchases and sells thir …
  • 3M Company:企業のM&A・事業提携・投資動向
    3M Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's 3M Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • City Utilities of Springfield:企業の戦略的SWOT分析
    City Utilities of Springfield - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Sanofi (SAN):企業の財務・戦略的SWOT分析
    Sanofi (SAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • BioDot Inc-医療機器分野:企業M&A・提携分析
    Summary BioDot Inc (BioDot) is a healthcare products provider that manufactures low volumes of fluids and powder dispensing products. The company offers lateral flow, immunoblots, biojet, airjet, dry chemistry, bio chips, low volume PCR, glucose biosensors, biosensors, polyject and dispo powder disp …
  • California Water Service Group (CWT):企業の財務・戦略的SWOT分析
    Summary California Water Service Group (California Water Service) is a utility service provider that offers wastewater services and water operation and maintenance services. The utility provides services such as water and wastewater utility services, and operating water and wastewater systems servic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆